UnitedHealth Group Inc (UNH) Expected to Earn Q1 2019 Earnings of $2.88 Per Share
UnitedHealth Group Inc (NYSE:UNH) – Equities research analysts at Oppenheimer issued their Q1 2019 EPS estimates for UnitedHealth Group in a research note issued to investors on Tuesday. Oppenheimer analyst M. Wiederhorn anticipates that the healthcare conglomerate will post earnings per share of $2.88 for the quarter. Oppenheimer has a “Outperform” rating and a $240.00 price target on the stock. Oppenheimer also issued estimates for UnitedHealth Group’s Q2 2019 earnings at $3.05 EPS, Q3 2019 earnings at $3.26 EPS, Q4 2019 earnings at $3.15 EPS and FY2019 earnings at $12.33 EPS.
UNH has been the subject of a number of other reports. Goldman Sachs Group initiated coverage on shares of UnitedHealth Group in a research note on Wednesday, January 3rd. They set a “buy” rating and a $269.00 price target for the company. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Morgan Stanley boosted their price objective on shares of UnitedHealth Group from $215.00 to $235.00 and gave the company an “overweight” rating in a research report on Wednesday, October 18th. ValuEngine cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 5th. Finally, Leerink Swann reissued a “buy” rating and issued a $240.00 price objective (up from $225.00) on shares of UnitedHealth Group in a research report on Wednesday, October 18th. Three equities research analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the company. UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $239.70.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping analysts’ consensus estimates of $2.50 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.57 billion. During the same period in the previous year, the company earned $2.11 EPS. The firm’s revenue for the quarter was up 9.5% compared to the same quarter last year.
In other news, insider Thomas E. Roos sold 975 shares of the business’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the sale, the insider now owns 24,630 shares in the company, valued at approximately $5,060,726.10. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Kenneth Irwin Shine sold 457 shares of the business’s stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total transaction of $96,440.71. The disclosure for this sale can be found here. In the last 90 days, insiders sold 34,630 shares of company stock valued at $7,669,416. Company insiders own 0.89% of the company’s stock.
Several large investors have recently bought and sold shares of UNH. Blue Chip Partners Inc. bought a new position in shares of UnitedHealth Group during the 2nd quarter worth approximately $110,000. Bruderman Asset Management LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter worth approximately $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its stake in shares of UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after acquiring an additional 520 shares in the last quarter. BDO Wealth Advisors LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter worth approximately $121,000. Finally, Acrospire Investment Management LLC raised its stake in shares of UnitedHealth Group by 130.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after acquiring an additional 400 shares in the last quarter. Institutional investors and hedge funds own 86.09% of the company’s stock.
TRADEMARK VIOLATION WARNING: “UnitedHealth Group Inc (UNH) Expected to Earn Q1 2019 Earnings of $2.88 Per Share” was first posted by American Banking News and is the property of of American Banking News. If you are reading this article on another website, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.americanbankingnews.com/2018/01/17/unitedhealth-group-inc-unh-expected-to-earn-q1-2019-earnings-of-2-88-per-share.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.